Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

199.32 USD -1.94 (-0.96%)
Streaming Delayed Price Updated: 12:09 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
BRIEF-U.S. appeals court rejects Teva appeal in Lilly patent case over Alimta
Jan 12 (Reuters) - U.S. Appeals Court rules for Eli Lilly and against Teva Pharmaceutical in Alimta patent case -- court ruling 
Tags companyNews
From Reuters: Company News
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Tags LLY NVS PFE
From Motley Fool
What pharma investors ought to do after Donald Trump fires a salvo
Reduce exposure to those industries on fears of a drug-price crackdown, says Nigam Arora. 
Tags Pharmaceuticals LABD PPH
From MarketWatch
BRIEF-Eli Lilly and Merck expand immuno-oncology collaboration
* Eli Lilly and co - financial details of collaboration were not disclosed. 
Tags companyNews
From Reuters: Company News
Incyte's Prospects Get Even Brighter With Merck Announcement
Tags MRK LLY INCY
From Motley Fool
This Could Very Well Be the Greatest Drug Advancement in a Decade
Tags LLY BIIB
From Motley Fool
Why Aratana Therapeutics Inc. Rocketed 42.7% Higher in 2016
Tags LLY PETX
From Motley Fool
Five unpopular, but prudent, things for investors to do near Dow 20,000
It’s time to sell over-owned stocks and trim some others, says Nigam Arora. 
Tags JNJ TTEK Manufacturing
From MarketWatch
The MedTech Group: 2017 Top Picks And Catalysts
Over the past year, the gap between MedTech stocks and the S&P index has narrowed significantly, and these are currently trading ... 
Tags BSX Eurozone PODD
From Benzinga
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
Tags MRK LLY BMY
From Motley Fool
BRIEF-Lilly to adjust organization and leadership structure to better align with growth opportunities
* Lilly to adjust organization and leadership structure to better align with growth opportunities 
Tags companyNews
From Reuters: Company News
BRIEF-U.S. FDA approves supplemental New Drug Applications for three Type 2 diabetes medicines
* U.S. FDA approves supplemental new drug applications to include landmark data in product labels for synjardy (empagliflozin/metformin hydrochloride), synjardy xr (empagliflozin/metformin... 
Tags companyNews
From Reuters: Company News
Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In Court
Drugmaker Eli Lilly will likely add a rheumatoid arthritis drug to its FDA-approved repertoire this month, Credit Suisse says. 
Tags Technology
From Investor's Business Daily
My Worst Predictions for Biotech in 2016
Tags KITE BIIB EDIT
From Motley Fool
Two Key FDA Decisions To Watch Out For In January 2017
Several drug companies could see regulatory milestones passed in January 2017. Here's a look at a couple of important regulatory events scheduled for this month. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: CEO Exclusive
Amgen expects to compete robustly in the anti-CGRP migraine market vs. Alder BioPharma, Teva Pharmaceutical and Eli Lilly. 
Tags Technology
From Investor's Business Daily
In the age of Uber and Lyft, it’s still hard for some Americans to get to the doctor
When a researcher first started looking at high diabetes rates among Bangladeshi Americans, transportation was the heart of the problem. 
Tags SPX Retail Personal Finance
From MarketWatch
Johnson & Johnson's 4 Biggest Catalysts in 2017
Tags ABBV JNJ LLY
From Motley Fool
UPDATE 1-U.S. FTC requires divestitures in $13.53 bln Boehringer-Sanofi deal
WASHINGTON, Dec 28 (Reuters) - German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would... 
Tags companyNews
From Reuters: Company News
A Preview Of January PDUFA Dates
Biopharma companies did not have much to write home about in the year 2016, as negative news flow on price gouging hit many stocks in ... 
Tags XBI News General
From Benzinga
VTV, USB, LLY, LMT: ETF Inflow Alert
Symbols mentioned in this story: VTV, USB, LLY, LMT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Expect Availability Of Biogen's Newly Approved Spinraza In Just One Week
Biogen Inc (NASDAQ: BIIB) said its newly approved Spinraza (nusinersen) would be available in just one week time. Spinraza is approved ... 
Tags General News Previews
From Benzinga
Sanofi sues Novo Nordisk over diabetes drugs in the U.S.
PARIS/NEW YORK, Dec 27 (Reuters) - France's Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many... 
Tags companyNews
From Reuters: Company News
Migraine drugs may repeat rheumatoid arthritis success
Dec 23 (Reuters) - Nearly two decades ago, several drugs to treat rheumatoid arthritis hit the shelves in rapid succession, opening up a huge market for the treatment of the autoimmune joint disorder. 
Tags companyNews
From Reuters: Company News
J&J Back In Talks With Actelion, Teva Settles Corruption Probe
Several tuck-in deals and licensing agreements were announced this week while healthcare giant Johnson & Johnson is back in exclusive talks with Actelion regarding a possible deal. 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Gilead Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead, which is down 25.2%. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
6 Worst Biotech Stocks Of 2016
The biotech space is inherently fraught with risks, risks of failures in clinical trials, regulatory logjams, political policies ... 
Tags OPHT NVAX LLY
From Benzinga
The Most Likely Incyte Acquisition Deal for 2017?
Tags GILD LLY INCY
From Motley Fool
Trump health secretary nominee has bought and sold $300,000 in health care stocks while in office
While sponsoring many health-related bills in the House. 
Tags Construction and Materials Retail LLY
From MarketWatch
Two Lessons From My Biogen Trade
One can be wrong and make money and be right and lose money. Here is how I made money on Biogen Inc. 
Tags Options Pharma/Biotech
From Blogs - TalkMarkets
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.